Exicon Co., Ltd. — Board/Management Information 2016

Jul 4, 2016

Copenhagen, 2016-07-04 08:39 CEST (GLOBE NEWSWIRE) -- Exiqon has received a
proposal from Qiagen N.V. today, where Qiagen N.V. nominates Peer M. Schatz,
Roland Sackers and Axel Backheuer as candidates for election to the supervisory
board at the extraordinary general meeting on 5 July 2016.

Erik Walldén, Thorleif Krarup, Michael Nobel, Per Wold-Olsen and Rodney Turner
will resign as members of the Company’s supervisory board while Hans Henrik
Chrois Christensen has resigned as Chief Financial Officer.

Additional information

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)

About Exiqon

At Exiqon, we advance the research of when and where genes are expressed. We
empower scientists across the world with best-in-class products and
user-friendly business solutions designed to transform workflows in our
industry. Exiqon operates in two business areas: Exiqon Life Sciences is a
leading provider of flexible solutions for gene expression analysis. Academia,
biotech and pharmaceutical companies around the world use Exiqon’s research
products to make ground-breaking discoveries. Exiqon Diagnostics collaborates
with diagnostic and pharmaceutical companies to develop novel molecular
diagnostic tests for early detection of diseases, which can help physicians
make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For
more information about us, please visit www.exiqon.com